Eliminating OVD need via FLACS

Article

Phacoemulsification and intraocular lens implantation can be performed without an ophthalmic viscosurgical device (OVD) by using a femtosecond laser-assisted procedure (FLACS), according to researchers from the Institute for Vision Science, Ruhr University Eye Clinic, Bochum, Germany.

Phacoemulsification and intraocular lens implantation can be performed without an ophthalmic viscosurgical device (OVD) by using a femtosecond laser-assisted procedure (FLACS), according to researchers from the Institute for Vision Science, Ruhr University Eye Clinic, Bochum, Germany.

According to the researchers, performing FLACS without OVD poses no additional risk to the corneal endothelium compared with patients whose surgery was performed with standard phacoemulsification using OVD.

Reporting in the Journal of Refractive Surgery, the researchers conducted a prospective, randomized, single-centre trial of 74 eyes in 37 patients diagnosed as having significant cataracts in both eyes.

 In all of the patients, one eye was randomized to receive standard phacoemulsification with OVD. The other eye was treated with a femtosecond laser, and the subsequent manual part of the procedure was performed without using OVD. The patients were followed for 6 months.

The researchers found that among all the eyes, there were no significant differences in:

• major complications (none in either group)

• overall surgery time (non-OVD: 375 ± 81 seconds; OVD: 362 ± 43 seconds)

• the quantity of fluid passing through the eyes (non-OVD: 187 ± 35 mL; OVD: 186 ± 27 mL)

• endothelial cell loss after 6 months (non-OVD: −2.4%; OVD: −2.7%)

 

• central corneal thickness at 1 week postoperatively (non-OVD: 575 ± 45 µm; OVD: 573 ± 46 µm;)

• corrected distance visual acuity (logMAR non-OVD: 0.024; OVD: 0.038).

The researchers added that at 1 day post-surgery, 1 patient in the non-OVD group experienced intraocular pressure >25 mmHg, compared to 3 patients in the OVD group.

 

To read the abstract of the study, click here

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.